Literature DB >> 2440278

H3 receptor assay in electrically-stimulated superfused slices of rat brain cortex; effects of N alpha-alkylated histamines and impromidine analogues.

J F van der Werf, G J Bijloo, A van der Vliet, A Bast, H Timmerman.   

Abstract

The release of the putative neurotransmitter histamine (HA) from rat brain cortex slices is under negative feedback control by an HA autoreceptor. This autoreceptor has been postulated to belong to a new class of HA receptors, H3. To verify this hypothesis we have developed an assay using superfused rat brain cortex slices. The HA transmitter pool is labelled by incubation of the slices with the precursor 3H-histidine; 3H-HA is estimated after separation by column chromatography. Release of HA was found both after K+-induced depolarization and electrical field stimulation. The latter resulted in higher and more reproducible HA release. Electrically induced HA release could be fully inhibited in a concentration dependent way by exogenous HA in the superfusion buffer. N alpha-alkylated histamines also showed agonistic activity. The action of exogenous HA was totally blocked by the potent H2 agonist impromidine and some of its analogues.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2440278     DOI: 10.1007/bf02074680

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  8 in total

Review 1.  An overview of subcellular localization, release and termination of action of amine, amino acid and peptide neurotransmitters in the central nervous system.

Authors:  A H Mulder
Journal:  Prog Brain Res       Date:  1982       Impact factor: 2.453

2.  A procedure for the isolation of noradrenaline (together with adrenaline), dopamine, 5-hydroxytryptamine and histamine from the same tissue sample using a single column of strongly acidic cation exchange resin.

Authors:  C Atack; T Magnusson
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1978-01

3.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

Authors:  A DeLean; P J Munson; D Rodbard
Journal:  Am J Physiol       Date:  1978-08

4.  Stereoselectivity of the histamine H3-presynaptic autoreceptor.

Authors:  J M Arrang; J C Schwartz; W Schunack
Journal:  Eur J Pharmacol       Date:  1985-10-29       Impact factor: 4.432

5.  Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor.

Authors:  J M Arrang; M Garbarg; J C Schwartz
Journal:  Nature       Date:  1983-04-28       Impact factor: 49.962

6.  Autoregulation of histamine release in brain by presynaptic H3-receptors.

Authors:  J M Arrang; M Garbarg; J C Schwartz
Journal:  Neuroscience       Date:  1985-06       Impact factor: 3.590

7.  Histamine H2-binding on guinea pig cerebral cortex.

Authors:  G J Sterk; M W van der Schaar; B Rademaker; H van der Goot; H Timmerman
Journal:  Agents Actions       Date:  1986-04

8.  The influence of guanidino and isothiourea groups in histaminergic compounds on H2-activity.

Authors:  G J Sterk; H van der Goot; H Timmerman
Journal:  Agents Actions       Date:  1986-04
  8 in total
  4 in total

Review 1.  Plenary lecture. A third histamine receptor subtype: characterisation, localisation and functions of the H3-receptor.

Authors:  J C Schwartz; J M Arrang; M Garbarg; H Pollard
Journal:  Agents Actions       Date:  1990-04

2.  Autoinhibition of histamine release by H3 receptors in rat brain cortex depends on stimulation frequency.

Authors:  A van der Vliet; A Bast; H Timmerman
Journal:  Agents Actions       Date:  1990-04

3.  Pharmacological properties of the hydroxylated histamine, (+/-)-4(5)-(2-amino-1-hydroxyethyl)-imidazole.

Authors:  T Ishikawa; Y Kamisaki; T Itoh
Journal:  Agents Actions       Date:  1989-03

4.  Involvement of presynaptic H3 receptors in the inhibitory effect of histamine on serotonin release in the rat brain cortex.

Authors:  K Fink; E Schlicker; A Neise; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-11       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.